Korean JLK Inspection said yesterday that it launched its AIHub artificial intelligence-powered medical image diagnostics platform.
The newly launched AIHub system is designed to analyze images from a number of different imaging modalities, including magnetic resonance imaging, computed tomography, X-ray and mammography, the Seoul-based company said.
JLK Inspection claims the system can detect and monitor for more than 30 medical conditions in 14 regions of the body. The company added that the system is focused on brain diseases and conditions including ischemic stroke, hemorrhagic stroke, brain aneurysm and Alzheimer’s disease, as well as lung cancer, prostate cancer, breast cancer, coronary artery disease and other digital pathology.
“We are excited to show how we are able to assist users with quantitative analysis of their medical images at their own convenience. The ability to provide optimal diagnosis support based on deep learning technologies, unique algorithms and imaging procession techniques will be a great benefit to all patients, whether suffering from minor or major ailments,” CEO Won Tae Kim said in a press release.
JLK Inspection said that it has raised over $17 million so far in venture capital funding, and that it is planning an initial public offering in Korea some time during the second half of next year.
